WHO ICTRP trial
A prospective, open-label, one-arm, multicenter clinical study for apatinib in…
ChiCTR1900020503 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR1900020503 |
|---|---|
| Public title | A prospective, open-label, one-arm, multicenter clinical study for apatinib in the treatment of advanced Colorectal cancer been failed from second-line chemotherapy |
| Scientific title | A prospective, open-label, one-arm, multicenter clinical study for apatinib in the treatment of advanced Colorectal cancer been failed from second-line chemotherapy |
| Primary sponsor | Peking University Shenzhen Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Treatment study |
| Phase | II (Phase II study) |
| Countries | China |
| Conditions | metastatic colorectal cancer |
| Interventions | Experimental Group:Apatinb |
| Registration date | Jan 3, 2019 |
| Target size | Experimental Group:48 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: